ArticleBiomedicines2025

Combination of Brentuximab Vedotin and Pembrolizumab as Salvage Treatment Before Autologous Stem Cell Transplantation and Maintenance in Patients with Relapsed/Refractory Hodgkin Lymphoma.

Hanne Massa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.